Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 14;10(1):23.
doi: 10.1186/s12348-020-00214-2.

Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease

Affiliations
Review

Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease

Cristhian A Urzua et al. J Ophthalmic Inflamm Infect. .

Abstract

Purpose: To describe distinctive stages of Vogt-Koyanagi-Harada (VKH) disease: initial-onset acute versus chronic recurrent disease.

Methods: A comprehensive literature review regarding stages and clinical presentations of VKH disease was conducted.

Results: Despite a list of signs that has been described as characteristic features of early or late phases of VKH disease, the current classification -developed by an international committee and published in 2001- does not consider a distinction regarding the time from onset of disease symptoms, and specific findings observed at certain time point from the symptoms presentation and outcomes related to the stage of VKH disease. In that sense, chronic recurrent VKH disease is more refractory to treatment and is associated with a higher rate of complications. Accordingly, this subset of VKH patients has poorer functional and anatomical outcomes than patients with an initial-onset acute disease.

Conclusions: An early clear distinction of VKH phenotype [Initial-onset acute versus chronic recurrent disease] should be considered in each clinical scenario, evaluating the delay in diagnosis and the clinical presentation, since it may help clinicians to perform a correct disease prognosis categorization and thus to make treatment decisions in terms of potential refractoriness or expected clinical outcomes.

Keywords: Categorization; Chronic VKH; Initial-onset acute VKH; Vogt-Koyanagi-Harada disease.

PubMed Disclaimer

Conflict of interest statement

No Competing Interests to be declared.

References

    1. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265–292. doi: 10.1016/S0039-6257(05)80105-5. - DOI - PubMed
    1. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652. doi: 10.1016/S0002-9394(01)00925-4. - DOI - PubMed
    1. Giordano VE, Schlaen A, Guzmán-Sánchez MJ, Couto C. Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina. Int J Ophthalmol. 2017;10:98–102. - PMC - PubMed
    1. Liberman P, Gauro F, Berger O, Urzua CA. Causes of uveitis in a tertiary Center in Chile: A cross-sectional retrospective review. Ocul Immunol Inflamm. 2015;23:339–345. doi: 10.3109/09273948.2014.981548. - DOI - PubMed
    1. Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606–614. doi: 10.1016/j.ophtha.2006.07.040. - DOI - PubMed

LinkOut - more resources